Summing up, the role of Gal-9 in cancer immunity implicates a reduced survival of patients with Gal-9 expressing cancers, while its functions in apoptosis, cancer cell adhesion, and metastasis could explain a better outcome in Gal-9 expressing ovarian cancers. This evidence concerns the gene LGALS9 and ovarian cancer.